H1B Salary Data

Home › Employers › TopCare Medical Group Inc.

TopCare Medical Group Inc.: H-1B salaries and sponsorship

TopCare Medical Group Inc. filed 5 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $201,000.

Applications (LCAs)5
Certified4
Employer addressDallas, TX
H-1B dependent employerNo
Median offered salary$201,000
Middle half of salaries$200,000–$202,000
10th–90th percentile$200,000–$202,000

Does TopCare Medical Group Inc. sponsor H-1B visas?

TopCare Medical Group Inc. filed 5 labor condition applications in fiscal years 2023–2026, the latest submitted on Jul 17, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Pediatrician5$201,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20232$200,000
FY20242$201,000
FY20251$202,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Pediatrician$202,000
Level II
Dallas, TXJul 17, 2025Oct 14, 2025Certified
Pediatrician$202,000
Level II
San Antonio, TXJul 19, 2024Sep 2, 2024Certified
Pediatrician$200,000
Level II
San Antonio, TXNov 4, 2023Dec 1, 2023Certified
Pediatrician$200,000
Level II
San Antonio, TXSep 19, 2023Oct 30, 2023Certified
Pediatrician$200,000
Level II
San Antonio, TXSep 19, 2023Oct 1, 2023Withdrawn

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).